Medicines and Healthcare products Regulatory Agency (MHRA) – MHRA implements new regulatory framework on decentralised manufacture
MHRA has provided information on the new regulations for decentralised manufacture which come into effect on 23 July 2025. Point of care and modular manufacture are collectively called decentralised manufacture. These processes allow medicinal products to be made at or close to a patient’s location for administration of the medicine. Please find details including a webinar recording of these new MHRA regulations held on 28 January 2025 here. Guidance is expected to be published in early summer 2025.
News reported on the 2nd of April 2025 in Catapult’s regulatory round-up, read the entire report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (20 mai 2025). Medicines and Healthcare products Regulatory Agency (MHRA) – MHRA implements new regulatory framework on decentralised manufacture. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/13yf6





